News & Insights

In the News

September 29, 2020 - Source: Law360

Jarred Reiling, Gabriel Krimm and Joel McElvain counsel Jacobus Pharmaceutical before a Florida federal court, which dismissed a lawsuit from Catalyst Pharmaceuticals that claimed the FDA unlawfully approved a lower-cost version of a drug


Go to the article